SEC Comment Letter for Rezolute, Inc. (RZLT) (CIK 0001509261) (RZLT) — Dec 4, 2019
Rezolute, Inc. (RZLT) (CIK 0001509261)
Date: Dec. 4, 2019 · CIK: 0001509261 · Accession: 0000000000-19-016086
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234766
Letter
December 3, 2019 Nevan Elam Chief Executive Officer Rezolute, Inc. 201 Redwood Shores Parkway, Suite 315 Redwood City, CA 94065 Re:Rezolute, Inc. Registration Statement on Form S-1 Filed November 18, 2019 File No. 333-234766 Dear Mr. Elam: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Michael L. Weiner, Esq.
Show Raw Text
December 3, 2019
Nevan Elam
Chief Executive Officer
Rezolute, Inc.
201 Redwood Shores Parkway, Suite 315
Redwood City, CA 94065
Re:Rezolute, Inc.
Registration Statement on Form S-1
Filed November 18, 2019
File No. 333-234766
Dear Mr. Elam:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Michael L. Weiner, Esq.